Lisinopril and Hydrochlorothiazide
- Product NDC
- 53002-2308
- 11-digit product format
- 530022308
- Labeler code
- 53002
- Product ID
- 53002-2308_4b74a63c-abdd-4906-883e-0eb567b245c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-10-04
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2308-0 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 53002-2308-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2308 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RPK PHARMACEUTICALS, INC.] | 1 | Legacy NDC, 2 package rows | 20220331_0c10b2c5-ca18-4212-9832-b32bf6b747d4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2308-0 | 53002230800 | 100 TABLET in 1 BOTTLE (53002-2308-0) | 100 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |
| 53002-2308-3 | 53002230803 | 30 TABLET in 1 BOTTLE (53002-2308-3) | 30 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |